Maria Katsara - Search Results

Year	Number of Results
2005	1
2006	2
2008	7
2009	2
2010	3
2011	1
2014	1
2017	2
2018	2
2020	1
2024	0

1

Editorial: Multiple Sclerosis: Pathogenesis and Therapeutics.

Katsara M, Apostolopoulos V. Katsara M, et al. Med Chem. 2018 Feb 6;14(2):104-105. doi: 10.2174/157340641402180206092504. Med Chem. 2018. PMID: 29453907 No abstract available.

2

Multiple Sclerosis: Immunopathology and Treatment Update.

Dargahi N, Katsara M, Tselios T, Androutsou ME, de Courten M, Matsoukas J, Apostolopoulos V. Dargahi N, et al. Among authors: katsara m. Brain Sci. 2017 Jul 7;7(7):78. doi: 10.3390/brainsci7070078. Brain Sci. 2017. PMID: 28686222 Free PMC article. Review.

3

Methods to measure T-cell responses.

Plebanski M, Katsara M, Sheng KC, Xiang SD, Apostolopoulos V. Plebanski M, et al. Among authors: katsara m. Expert Rev Vaccines. 2010 Jun;9(6):595-600. doi: 10.1586/erv.10.53. Expert Rev Vaccines. 2010. PMID: 20518715 Free article. Review.

4

Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab.

Florou D, Katsara M, Feehan J, Dardiotis E, Apostolopoulos V. Florou D, et al. Among authors: katsara m. Brain Sci. 2020 Oct 20;10(10):758. doi: 10.3390/brainsci10100758. Brain Sci. 2020. PMID: 33092190 Free PMC article. Review.

5

Towards immunotherapeutic drugs and vaccines against multiple sclerosis.

Katsara M, Matsoukas J, Deraos G, Apostolopoulos V. Katsara M, et al. Acta Biochim Biophys Sin (Shanghai). 2008 Jul;40(7):636-42. doi: 10.1111/j.1745-7270.2008.00444.x. Acta Biochim Biophys Sin (Shanghai). 2008. PMID: 18604455 Free article. Review.

6

Round and round we go: cyclic peptides in disease.

Katsara M, Tselios T, Deraos S, Deraos G, Matsoukas MT, Lazoura E, Matsoukas J, Apostolopoulos V. Katsara M, et al. Curr Med Chem. 2006;13(19):2221-32. doi: 10.2174/092986706777935113. Curr Med Chem. 2006. PMID: 16918350 Review.

7

The good, the bad and the ugly: how altered peptide ligands modulate immunity.

Katsara M, Minigo G, Plebanski M, Apostolopoulos V. Katsara M, et al. Expert Opin Biol Ther. 2008 Dec;8(12):1873-84. doi: 10.1517/14712590802494501. Expert Opin Biol Ther. 2008. PMID: 18990075 Review.

8

Strategies used for MUC1 immunotherapy: human clinical studies.

Tang CK, Katsara M, Apostolopoulos V. Tang CK, et al. Among authors: katsara m. Expert Rev Vaccines. 2008 Sep;7(7):963-75. doi: 10.1586/14760584.7.7.963. Expert Rev Vaccines. 2008. PMID: 18767946 Review.

9

Cyclization of PLP_139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis.

Lourbopoulos A, Matsoukas MT, Katsara M, Deraos G, Giannakopoulou A, Lagoudaki R, Grigoriadis N, Matsoukas J, Apostolopoulos V. Lourbopoulos A, et al. Among authors: katsara m. Bioorg Med Chem. 2018 May 15;26(9):2221-2228. doi: 10.1016/j.bmc.2017.12.024. Epub 2017 Dec 19. Bioorg Med Chem. 2018. PMID: 29681483

10

A complementary role for the tetraspanins CD37 and Tssc6 in cellular immunity.

Gartlan KH, Belz GT, Tarrant JM, Minigo G, Katsara M, Sheng KC, Sofi M, van Spriel AB, Apostolopoulos V, Plebanski M, Robb L, Wright MD. Gartlan KH, et al. Among authors: katsara m. J Immunol. 2010 Sep 15;185(6):3158-66. doi: 10.4049/jimmunol.0902867. Epub 2010 Aug 13. J Immunol. 2010. PMID: 20709950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

21 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year